Announcement in line with the article 282 of the ASE regulation
According to the PD 51/92 and article 282 of the ASE regulation we inform the investor community that Aklepios International GmbH has informed us about a transaction on the 29th of June 2007.
In particular, prior to the transaction "Aklepios International GmbH" had 12.149.532 shares out of a total number of shares of 86.735.980. The percentage of voting rights as well as the percentage of the Company's Share capital controlled by "Aklepios International GmbH" was 14,01%. After the transaction and the acquisition of 14.500.000 shares "Aklepios International GmbH" has 26.649.532 shares and controls 30,7249% of the voting rights and the "Athens Medical Center SA" share Capital.
Note that Aklepios International GmbH is a 100% subsidiary of Aklepios Kliniken Verwaltungsgesellschaft mbH which is 100% subsidiary of Aklepios Kliniken GmbH which is 100% controlled by Dr. Bernard gr. Broermann.